Literature DB >> 9256315

Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration.

A M Marmont1, M T van Lint, F Gualandi, A Bacigalupo.   

Abstract

A 46 year woman with severe long-lasting SLE received an autologous bone marrow transplantation utilising CD34+ haematopoietic progenitors following a 3log T-lymphocyte depletion. The immunosuppressive regimen (conditioning) consisted of 15mg/kg Thiotepa followed by 100 mg/kg of cyclophosphamide over 2d. Granulocytic recovery was aided by G-CSF. The post-transplant course was uneventful, and a good clinical and immunologic remission (ANA negativisation) was achieved. This is the first case of SLE having received an autologous progenitor cell transplant for the autoimmune disease by itself, unaccompanied by a haematologic condition requiring transplantation. The potential, advantages and limits of this procedure, which are currently being explored worldwide, are briefly discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9256315     DOI: 10.1177/096120339700600613

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  28 in total

Review 1.  Bone marrow transplantation in the treatment of systemic sclerosis.

Authors:  F Viganego; R Nash; D E Furst
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

Review 2.  Stem cell transplantation for autoimmune diseases.

Authors:  J Moore; P Brooks
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

Review 4.  Immunotherapy of systemic sclerosis.

Authors:  Rebecca Manno; Francesco Boin
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

5.  Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).

Authors:  Perrine Guillaume-Jugnot; Manuela Badoglio; Myriam Labopin; Louis Terriou; Ibrahim Yakoub-Agha; Thierry Martin; Bruno Lioure; Zora Marjanovic; Didier Blaise; Stéphanie Nguyen; Gregory Pugnet; Anne Huynh; Christophe Deligny; Christophe Seinturier; Frédéric Garban; Laure Swiader; Jacques-Olivier Bay; Thorsten Braun; Régis Peffault de Latour; Marie Thérèse Rubio; Dominique Farge
Journal:  Clin Rheumatol       Date:  2019-01-21       Impact factor: 2.980

Review 6.  Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review.

Authors:  Bin Liu; ShangAn Shu; Thomas P Kenny; Christopher Chang; Patrick S C Leung
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

7.  Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis.

Authors:  Xianghua Huang; Wencui Chen; Guisheng Ren; Liang Zhao; Jinzhou Guo; Dehua Gong; Caihong Zeng; Weixin Hu; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-12       Impact factor: 8.237

8.  Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.

Authors:  Marcelo C Pasquini; Julio Voltarelli; Harold L Atkins; Nelson Hamerschlak; Xiaobo Zhong; Kwang Woo Ahn; Keith M Sullivan; George Carrum; Jeffrey Andrey; Christopher N Bredeson; Mitchell Cairo; Robert Peter Gale; Theresa Hahn; Jan Storek; Mary M Horowitz; Peter A McSweeney; Linda M Griffith; Paolo A Muraro; Steven Z Pavletic; Richard A Nash
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-13       Impact factor: 5.742

Review 9.  Clinical immunologic interventions for the treatment of type 1 diabetes.

Authors:  Lucienne Chatenoud; Katharina Warncke; Anette-G Ziegler
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 10.  [Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus].

Authors:  T Alexander; R Arnold; F Hiepe
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.